Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer
-
Published:2023-07
Issue:
Volume:188
Page:81-89
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Xu YiquanORCID, Yan JingjingORCID, Zhou ChengzhiORCID, Wu Lin, Wang HaiboORCID, Zhao Jun, Zhou Maolin, Wang Jingyi, Zheng XinlongORCID, Zhang Longfeng, Jiang KanORCID, Zheng XiaobinORCID, Miao QianORCID, Wu ShiwenORCID, Zou Zihua, lian Rong, He Yuange, Chen Rongrong, Yang Shanshan, Li Yujing, Chen Sihui, Lin GenORCID
Subject
Cancer Research,Oncology
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|